A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/277 (2006.01) A61K 31/07 (2006.01) A61K 31/203 (2006.01) A61K 31/275 (2006.01) A61K 31/335 (2006.01) A61K 38/17 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2430454
CDDO-compounds in combination with other chemotherapeutic agents induce and potentiate cytotoxicity and apoptosis in cancer cell. One class of chemotherapeutic agents include retinoids. Cancer therapies based on these combination therapies are provided, Also provided are methods to treat graft versus host diseases using the CDDO compounds.
Selon l'invention, des composés CDDO conjointement avec d'autres agents chimiothérapeutiques induisent et potentialisent une cytotoxicité et l'apoptose dans une cellule cancéreuse. Une classe d'agents chimiothérapeutiques comprend des rétinoïdes. L'invention concerne également des thérapies contre le cancer fondées sur ces polythérapies. L'invention concerne, en outre, des procédés permettant de traiter une réaction du greffon contres hôtes au moyen des composés CDDO.
Andreef Michael
Konopleva Marina
Sporn Michael
Board Of Regents The University Of Texas System
Goudreau Gage Dubuc
The Trustees Of Darmouth College
LandOfFree
Cddo-compounds and combination therapies thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cddo-compounds and combination therapies thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cddo-compounds and combination therapies thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1932336